Abstract: This invention relates to recombinant nucleic constructs comprising Type V CRISPR-Cas effector proteins, reverse transcriptases and extended guide nucleic acids and methods of use thereof for modifying nucleic acids in plants.
Type:
Grant
Filed:
January 26, 2024
Date of Patent:
May 19, 2026
Assignee:
Pairwise Piants Services, Inc.
Inventors:
Joseph Matthew Watts, Aaron Hummel, Yongjoo Kim, Shai Joshua Lawit, David Schwark